BASF is increasing the prices of its pharmaceutical excipients and APIs by at least 10% depending on the product group. The company said it is raising prices as a result of a rise in costs for raw materials, energy and labour.
BASF
Monday 4 April 2011
BASF increases prices
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment